Rathbones Group’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-680
| Closed | -$182K | – | 359 |
|
|
2020
Q1 | $182K | Hold |
680
| – | – | 0.01% | 289 |
|
|
2019
Q4 | $220K | Hold |
680
| – | – | 0.01% | 301 |
|
|
2019
Q3 | $186K | Hold |
680
| – | – | 0.01% | 306 |
|
|
2019
Q2 | $363K | Hold |
680
| – | – | 0.01% | 251 |
|
|
2019
Q1 | $343K | Hold |
680
| – | – | 0.01% | 251 |
|
|
2018
Q4 | $335K | Hold |
680
| – | – | 0.01% | 247 |
|
|
2018
Q3 | $622K | Hold |
680
| – | – | 0.02% | 206 |
|
|
2018
Q2 | $498K | Sell |
680
-353
| -34% | -$259K | 0.02% | 213 |
|
|
2018
Q1 | $1.65M | Sell |
1,033
-20
| -2% | -$31.9K | 0.07% | 139 |
|
|
2017
Q4 | $944K | Sell |
1,053
-134
| -11% | -$120K | 0.04% | 178 |
|
|
2017
Q3 | $427K | Hold |
1,187
| – | – | 0.02% | 223 |
|
|
2017
Q2 | $348K | Hold |
1,187
| – | – | 0.02% | 236 |
|
|
2017
Q1 | $418K | Hold |
1,187
| – | – | 0.02% | 224 |
|
|
2016
Q4 | $218K | Buy |
1,187
+134
| +13% | +$24.6K | 0.01% | 274 |
|
|
2016
Q3 | $271K | Sell |
1,053
-134
| -11% | -$34.5K | 0.01% | 253 |
|
|
2016
Q2 | $253K | Buy |
1,187
+47
| +4% | +$10K | 0.01% | 249 |
|
|
2016
Q1 | $235K | Hold |
1,140
| – | – | 0.01% | 252 |
|
|
2015
Q4 | $235K | Hold |
1,140
| – | – | 0.01% | 255 |
|
|
2015
Q3 | $187K | Buy |
1,140
+133
| +13% | +$21.8K | 0.01% | 277 |
|
|
2015
Q2 | $189K | Hold |
1,007
| – | – | 0.01% | 294 |
|
|
2015
Q1 | $166K | Hold |
1,007
| – | – | 0.01% | 306 |
|
|
2014
Q4 | $234K | Hold |
1,007
| – | – | 0.02% | 275 |
|
|
2014
Q3 | $182K | Hold |
1,007
| – | – | 0.01% | 279 |
|
|
2014
Q2 | $194K | Hold |
1,007
| – | – | 0.01% | 266 |
|
|
2014
Q1 | $183K | Hold |
1,007
| – | – | 0.01% | 261 |
|
|
2013
Q4 | $171K | Buy |
1,007
+287
| +40% | +$48.7K | 0.02% | 188 |
|
|
2013
Q3 | $113K | Hold |
720
| – | – | 0.01% | 246 |
|
|
2013
Q2 | $125K | Buy |
+720
| New | +$125K | 0.02% | 224 |
|